• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rethinking treatment approaches for FIGO stage IVB cervical cancer: personalized strategies and emerging therapies.

作者信息

Zeng Jing, Yin Rutie

机构信息

Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

Front Immunol. 2025 Apr 8;16:1567296. doi: 10.3389/fimmu.2025.1567296. eCollection 2025.

DOI:10.3389/fimmu.2025.1567296
PMID:40264775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12011788/
Abstract
摘要

相似文献

1
Rethinking treatment approaches for FIGO stage IVB cervical cancer: personalized strategies and emerging therapies.重新思考国际妇产科联盟（FIGO）IVB期宫颈癌的治疗方法：个性化策略与新兴疗法
Front Immunol. 2025 Apr 8;16:1567296. doi: 10.3389/fimmu.2025.1567296. eCollection 2025.
2
The new FIGO 2023 staging reclassification of patients with FIGO 2009 Stage IVB endometrial cancer correlates to progression-free and overall survival outcomes.国际妇产科联盟（FIGO）2023年对2009年IVB期子宫内膜癌患者的分期重新分类与无进展生存期和总生存期结果相关。
Gynecol Oncol Rep. 2024 Oct 5;56:101527. doi: 10.1016/j.gore.2024.101527. eCollection 2024 Dec.
3
Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis.伴有血行转移的IVB期宫颈癌的临床病理特征及生存分析
Transl Cancer Res. 2019 Aug;8(4):1217-1223. doi: 10.21037/tcr.2019.07.21.
4
Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literature.卡铂和紫杉醇作为 IVb 期宫颈癌初始治疗的疗效：7 例报告及文献复习。
J Gynecol Oncol. 2010 Jun;21(2):93-6. doi: 10.3802/jgo.2010.21.2.93. Epub 2010 Jun 30.
5
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.FIGO 卵巢癌分期 IVA 与 IVB：新辅助化疗的预后价值和预测价值。
Int J Gynecol Cancer. 2018 Mar;28(3):453-458. doi: 10.1097/IGC.0000000000001186.
6
Outcomes and toxicities for the treatment of stage IVB cervical cancer.IVB 期宫颈癌的治疗结果和毒性。
Arch Gynecol Obstet. 2012 Jun;285(6):1685-93. doi: 10.1007/s00404-011-2173-6. Epub 2011 Dec 16.
7
Rethinking the significance of surgery for uterine cervical cancer.重新思考宫颈癌手术的意义。
J Obstet Gynaecol Res. 2022 Mar;48(3):576-586. doi: 10.1111/jog.15112. Epub 2021 Dec 14.
8
Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study.同期放化疗的 IVB 期宫颈癌患者原发灶手术治疗：一项基于人群的研究。
J Gynecol Oncol. 2020 Jan;31(1):e8. doi: 10.3802/jgo.2020.31.e8. Epub 2019 Aug 2.
9
Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases.Müllerian 癌症 IV 期的亚分类在 2014 年 FIGO 分期系统中对腹外淋巴结转移的预后影响。
Int J Clin Oncol. 2021 Jul;26(7):1330-1335. doi: 10.1007/s10147-021-01908-w. Epub 2021 Mar 30.
10
The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.变革的时机：新 2023FIGO 分期标准对 IVB 期子宫内膜癌异质性和风险分层改善的报告。
Gynecol Oncol. 2023 Aug;175:32-40. doi: 10.1016/j.ygyno.2023.05.069. Epub 2023 Jun 13.

本文引用的文献

1
Standard of care treatment for stage IVB cervical cancer: A systematic review and meta-analysis.IVB期宫颈癌的标准治疗：一项系统评价与荟萃分析
Gynecol Oncol. 2024 Dec;191:259-264. doi: 10.1016/j.ygyno.2024.10.023. Epub 2024 Oct 30.
2
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.阿替利珠单抗联合贝伐珠单抗和化疗治疗转移性、持续性或复发性宫颈癌（BEATcc）：一项随机、开放标签、3 期临床试验。
Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1.
3
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.一线帕博利珠单抗+化疗对比安慰剂+化疗用于持续性、复发性或转移性宫颈癌：KEYNOTE-826 的最终总生存结果。
J Clin Oncol. 2023 Dec 20;41(36):5505-5511. doi: 10.1200/JCO.23.00914. Epub 2023 Nov 1.
4
Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases.对新诊断的 IVB 期宫颈癌伴同步寡转移灶的原发病灶和转移灶，行根治性放疗作为初始治疗策略。
Radiat Oncol. 2023 Sep 26;18(1):159. doi: 10.1186/s13014-023-02320-6.
5
Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review.根治性盆腔放疗用于新诊断的 IVB 期宫颈癌患者：系统评价。
Int J Gynecol Cancer. 2023 Jul 3;33(7):1057-1062. doi: 10.1136/ijgc-2023-004465.
6
Metastatic extent-specific prognosis of women with stage IVB cervical cancer: multiple versus single distant organ involvement.IVB 期宫颈癌转移范围特异性预后：多处与单一远处器官转移。
Arch Gynecol Obstet. 2023 Feb;307(2):533-540. doi: 10.1007/s00404-022-06611-3. Epub 2022 May 21.
7
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.派姆单抗治疗持续性、复发性或转移性宫颈癌。
N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18.
8
Role of locoregional surgery in treating FIGO 2009 stage IVB cervical cancer patients: a population-based study.局部区域性手术在治疗 FIGO 2009 分期 IVB 期宫颈癌患者中的作用：一项基于人群的研究。
BMJ Open. 2021 Aug 11;11(8):e042364. doi: 10.1136/bmjopen-2020-042364.
9
Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy.将全骨盆放疗纳入 IVB 期宫颈癌治疗：一种新的治疗策略。
Gynecol Oncol. 2020 Jan;156(1):100-106. doi: 10.1016/j.ygyno.2019.10.033. Epub 2019 Dec 4.
10
Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study.同期放化疗的 IVB 期宫颈癌患者原发灶手术治疗：一项基于人群的研究。
J Gynecol Oncol. 2020 Jan;31(1):e8. doi: 10.3802/jgo.2020.31.e8. Epub 2019 Aug 2.